These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19525146)

  • 1. Targeted gene modifications in drug discovery and development.
    Cabaniols JP; Mathis L; Delenda C
    Curr Opin Pharmacol; 2009 Oct; 9(5):657-63. PubMed ID: 19525146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human embryonic stem cell technologies and drug discovery.
    Jensen J; Hyllner J; Björquist P
    J Cell Physiol; 2009 Jun; 219(3):513-9. PubMed ID: 19277978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo target validation using gene invalidation, RNA interference and protein functional knockout models: it is the time to combine.
    Vidalin O; Muslmani M; Estienne C; Echchakir H; Abina AM
    Curr Opin Pharmacol; 2009 Oct; 9(5):669-76. PubMed ID: 19646923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cell systems for drug discovery.
    Horrocks C; Halse R; Suzuki R; Shepherd PR
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):570-5. PubMed ID: 12951820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
    Crook JM; Kobayashi NR
    J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
    Braam SR; Passier R; Mummery CL
    Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2D and 3D cell microarrays in pharmacology.
    Gidrol X; Fouqué B; Ghenim L; Haguet V; Picollet-D'hahan N; Schaack B
    Curr Opin Pharmacol; 2009 Oct; 9(5):664-8. PubMed ID: 19520607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell technology for drug discovery and development.
    Hook LA
    Drug Discov Today; 2012 Apr; 17(7-8):336-42. PubMed ID: 22100998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
    Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
    Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for analysing and improving the expression and quality of recombinant proteins made in mammalian cells.
    Jenkins N; Meleady P; Tyther R; Murphy L
    Biotechnol Appl Biochem; 2009 May; 53(Pt 2):73-83. PubMed ID: 19397493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impedance-based cellular assay technologies: recent advances, future promise.
    McGuinness R
    Curr Opin Pharmacol; 2007 Oct; 7(5):535-40. PubMed ID: 17900985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Complex Production from the Drug Discovery Standpoint.
    Moarefi I
    Adv Exp Med Biol; 2016; 896():3-13. PubMed ID: 27165315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discovery from uncultivable microorganisms.
    Singh BK; Macdonald CA
    Drug Discov Today; 2010 Sep; 15(17-18):792-9. PubMed ID: 20656054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of 'stemness' and stem cell differentiation by microRNAs.
    Sartipy P; Olsson B; Hyllner J; Synnergren J
    IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnically diverse pluripotent stem cells for drug development.
    Fakunle ES; Loring JF
    Trends Mol Med; 2012 Dec; 18(12):709-16. PubMed ID: 23142148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of cell-based label-free technology in drug discovery.
    Xi B; Yu N; Wang X; Xu X; Abassi YA
    Biotechnol J; 2008 Apr; 3(4):484-95. PubMed ID: 18412175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput Protein Production (HTPP): a review of enabling technologies to expedite protein production.
    Koehn J; Hunt I
    Methods Mol Biol; 2009; 498():1-18. PubMed ID: 18988015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resonant waveguide grating biosensor for whole-cell GPCR assays.
    Fang Y; Ferrie AM; Tran E
    Methods Mol Biol; 2009; 552():239-52. PubMed ID: 19513654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors.
    Niwa A; Umeda K; Chang H; Saito M; Okita K; Takahashi K; Nakagawa M; Yamanaka S; Nakahata T; Heike T
    J Cell Physiol; 2009 Nov; 221(2):367-77. PubMed ID: 19562687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.